Mammalian target of rapamycin (mTOR) is a protein kinase involved in translation control and long-lasting synaptic plasticity. mTOR functions as the central component of two multi-protein signaling complexes, mTORC1 and mTORC2, which can be distinguished from each other based on their unique compositions and substrates. Although the majority of evidence linking mTOR function to synaptic plasticity comes from studies utilizing rapamycin, studies in genetically modified mice also suggest that mTOR couples receptors to the translation machinery for establishing long-lasting synaptic changes that are the basis for higher order brain function, including long-term memory. Finally, perturbation of the mTOR signaling cascade appears to be a common pathophysiological feature of human neurological disorders, including mental retardation syndromes and autism spectrum disorders.
Synaptic plasticity
Memory is 'stored' via the carefully regulated interaction of neuronal networks of the nervous system. The synapse is the essential cellular unit of memory and is a site of electrochemical communication between neurons; these connections are 'plastic'. In other words, the physiological responsiveness (i.e. the 'strength' of the synaptic connection) is modifiable. A more detailed review of the mechanisms underlying synaptic plasticity can be found elsewhere [1] . Importantly, synaptic plasticity is also defined temporally, with some alterations lasting only seconds whereas others persist over the lifetime of the organism [2, 3] . In vertebrates, long-term change in synaptic strength is often measured as long-term potentiation (LTP) and long-term depression (LTD) [1, 4, 5] . In invertebrates such as Aplysia, long-term facilitation (LTF) is used as a measure of synaptic plasticity [3, 6] .
The more durable forms of synaptic plasticity are conveyed biochemically via the expression of new proteins, both somatically and dendritically [3, 7] . The important role of protein synthesis in synaptic plasticity has been demonstrated in numerous experimental systems using a variety of pharmacological and genetic approaches [8] . Protein synthesis or translation is a highly regulated process that can be separated into three general phases: initiation, elongation and termination. The majority of known translational regulation occurs at the level of translation initiation. The coordinated activities of numerous initiation factors are required for this process (for reviews see Refs [5, 9] ). Central to the regulation of translation initiation is the activity of a ubiquitously expressed kinase, mammalian target of rapamycin (mTOR). In this review, we provide an overview of what is known about mTOR function, its biochemical interactions and its regulation during protein synthesis-dependent forms of synaptic plasticity and memory. We end the review with a discussion of the potential role of the mTOR signaling cascade in neurological disease and disorders.
mTOR: Central regulator of translational initiation mTOR function is influenced by the activities of neuronal surface receptors and channels including N-methyl-Daspartate receptors (NMDA-R), a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, brain-derived neurotrophic factor and dopaminergic and metabotropic glutamate receptors (mGluRs), which are vital for the induction and maintenance of LTP and LTD [10] [11] [12] [13] [14] . mTOR acts as a node of convergence downstream of these receptors and several signaling pathways that include phosphoinositide dependent kinase-1 (PDK1), phosphatidylinositol 3-kinase (PI3K), Akt and tuberous sclerosis complex proteins 1 and 2 (Tsc1/2) [5, [15] [16] [17] [18] . mTOR structure mTOR is a large (2549 amino acid, $250 kD) ubiquitously expressed multi-effector serine/threonine kinase that is a highly conserved homolog of the yeast protein, target of rapamycin (TOR). Rapamycin (or sirolimus) is a macrolide derived from soil bacterium [19] . The C-terminal end of mTOR contains several important elements, including the kinase catalytic domain (KIN) that is structurally similar to the catalytic site in PI3Ks but does not encode lipid kinase activity (Figure 1) . The KIN domain also contains a small region that is probably a site of phosphoregulation called the negative regulatory domain (NRD) or ''repressor domain '' [15,20] . This domain contains phosphorylation sites conserved in kinases with similar structure. Within this region, phosphorylation at threonine 2446, serine 2448 and serine 2481 are correlated with overall higher levels of mTOR activity. Of particular note is serine 2448, which is a target of Akt as well as p70 S6 kinase (S6K) [21] [22] [23] [24] . Some of these residues are autophosphorylated even in the presence of rapamycin, whereas others are substrates of the downstream effectors of mTOR itself, thereby providing multiple mechanisms for feedback regulation [15, 20] . Finally, adjacent to the KIN domain is the FKBP12-rapamycin binding domain (FRB), the site of inhibitory interaction between rapamycin and mTOR. Rapamycin bound to FK506 binding protein 12 (FKBP12, discussed later) 
